TreeWAS – Variant ID: rs3809346

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z63.8 Other specified problems related to primary support group	0.000	0.983	0.017
Z63 Other problems related to primary support group, including family circumstances	0.000	0.985	0.015
Z63.0 Problems in relationship with spouse or partner	0.000	0.985	0.015
Z63.5 Disruption of family by separation and divorce	0.000	0.987	0.013
Z63.4 Disappearance and death of family member	0.000	0.987	0.013
Z63.9 Problem related to primary support group, unspecified	0.000	0.989	0.011
Z63.7 Other stressful life events affecting family and household	0.000	0.989	0.011
Z63.3 Absence of family member	0.000	0.989	0.011
Z63.2 Inadequate family support	0.000	0.989	0.011
Z63.1 Problems in relationship with parents and in-laws	0.000	0.989	0.011
Z63.6 Dependent relative needing care at home	0.000	0.989	0.011
N83.0 Follicular cyst of ovary	0.000	0.992	0.008
I27.0 Primary pulmonary hypertension	0.000	0.992	0.008
I27.9 Pulmonary heart disease, unspecified	0.000	0.992	0.008
S90.9 Superficial injury of ankle and foot, unspecified	0.008	0.992	0.000
G54.9 Nerve root and plexus disorder, unspecified	0.000	0.994	0.006
I27 Other pulmonary heart diseases	0.000	0.994	0.006
S30.1 Contusion of abdominal wall	0.000	0.994	0.006
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.006	0.994	0.000
K92.1 Melaena	0.000	0.994	0.006
Y40.9 Systemic antibiotic, unspecified	0.006	0.994	0.000
Y43.4 Immunosuppressive agents	0.005	0.995	0.000
G54.0 Brachial plexus disorders	0.000	0.995	0.005
M06.0 Seronegative rheumatoid arthritis	0.005	0.995	0.000
I25.8 Other forms of chronic ischaemic heart disease	0.005	0.995	0.000
S90 Superficial injury of ankle and foot	0.005	0.995	0.000
G54 Nerve root and plexus disorders	0.000	0.995	0.005
S30.9 Superficial injury of abdomen, lower back and pelvis, part unspecified	0.000	0.995	0.005
I27.1 Kyphoscoliotic heart disease	0.000	0.995	0.005
S90.3 Contusion of other and unspecified parts of foot	0.005	0.995	0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.005	0.995	0.000
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.004	0.995	0.000
S30 Superficial injury of abdomen, lower back and pelvis	0.000	0.995	0.005
Y40 Systemic antibiotics	0.004	0.996	0.000
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.000	0.996	0.004
L81.4 Other melanin hyperpigmentation	0.000	0.996	0.004
E87.7 Fluid overload	0.000	0.996	0.004
M06.04 Seronegative rheumatoid arthritis (Hand)	0.004	0.996	0.000
C83.0 Small cell (diffuse)	0.000	0.996	0.004
O04.1 Incomplete, complicated by delayed or excessive haemorrhage	0.000	0.996	0.004
G54.8 Other nerve root and plexus disorders	0.000	0.996	0.004
Y43 Primarily systemic agents	0.004	0.996	0.000
Y40.7 Antifungal antibiotics, systemically used	0.004	0.996	0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.004	0.996	0.000
I25.1 Atherosclerotic heart disease	0.004	0.996	0.000
I27.8 Other specified pulmonary heart diseases	0.000	0.996	0.004
Y57.9 Drug or medicament, unspecified	0.004	0.996	0.000
Y52 Agents primarily affecting the cardiovascular system	0.004	0.996	0.000
S90.0 Contusion of ankle	0.004	0.996	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.004	0.996	0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.004	0.996	0.000
M06.08 Seronegative rheumatoid arthritis (Other)	0.004	0.996	0.000
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.004	0.996	0.000
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.004	0.996	0.000
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.004	0.996	0.000
Z87.7 Personal history of congenital malformations, deformations and chromosomal abnormalities	0.004	0.996	0.000
F60.3 Emotionally unstable personality disorder	0.000	0.996	0.004
S90.1 Contusion of toe(s) without damage to nail	0.004	0.996	0.000
Y52.1 Calcium-channel blockers	0.004	0.996	0.000
Y43.0 Antiallergic and antiemetic drugs	0.004	0.996	0.000
S90.7 Multiple superficial injuries of ankle and foot	0.004	0.996	0.000
S90.2 Contusion of toe(s) with damage to nail	0.004	0.996	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.004	0.996	0.000
G54.7 Phantom limb syndrome without pain	0.000	0.996	0.004
G54.5 Neuralgic amyotrophy	0.000	0.996	0.004
G54.3 Thoracic root disorders, not elsewhere classified	0.000	0.996	0.004
G54.1 Lumbosacral plexus disorders	0.000	0.996	0.004
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
Y40.5 Aminoglycosides	0.004	0.996	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.004	0.996	0.000
G54.2 Cervical root disorders, not elsewhere classified	0.000	0.996	0.004
O73.0 Retained placenta, without haemorrhage	0.000	0.996	0.004
I21.1 Acute transmural myocardial infarction of inferior wall	0.004	0.996	0.000
R09.3 Abnormal sputum	0.004	0.996	0.000
S71.1 Open wound of thigh	0.004	0.996	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.003	0.996	0.000
F60 Specific personality disorders	0.000	0.996	0.004
F60.9 Personality disorder, unspecified	0.000	0.996	0.003
S30.7 Multiple superficial injuries of abdomen, lower back and pelvis	0.000	0.996	0.003
G54.4 Lumbosacral root disorders, not elsewhere classified	0.000	0.997	0.003
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
Y40.2 Chloramphenicol group	0.003	0.997	0.000
Y40.8 Other systemic antibiotics	0.003	0.997	0.000
Y40.3 Macrolides	0.003	0.997	0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.000	0.997	0.003
Y46.6 Other and unspecified antiepileptics	0.003	0.997	0.000
Y40.4 Tetracyclines	0.003	0.997	0.000
Y43.2 Antineoplastic natural products	0.003	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
F60.7 Dependent personality disorder	0.000	0.997	0.003
G54.6 Phantom limb syndrome with pain	0.000	0.997	0.003
Y43.9 Primarily systemic agent, unspecified	0.003	0.997	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.003	0.997	0.000
Y43.6 Enzymes, not elsewhere classified	0.003	0.997	0.000
Y43.5 Acidifying and alkalising agents	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
I25 Chronic ischaemic heart disease	0.003	0.997	0.000
Y48.3 Local anaesthetics	0.003	0.997	0.000
Y57 Other and unspecified drugs and medicaments	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
O04.9 Complete or unspecified, without complication	0.000	0.997	0.003
S90.8 Other superficial injuries of ankle and foot	0.003	0.997	0.000
Y48 Anaesthetics and therapeutic gases	0.003	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
I25.4 Coronary artery aneurysm	0.003	0.997	0.000
S30.2 Contusion of external genital organs	0.000	0.997	0.003
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
Y58 Bacterial vaccines	0.003	0.997	0.000
Q38.7 Pharyngeal pouch	0.003	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
O04 Medical abortion	0.000	0.997	0.003
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
F60.8 Other specific personality disorders	0.000	0.997	0.003
Y59.0 Viral vaccines	0.003	0.997	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.000	0.997	0.003
Y42.1 Thyroid hormones and substitutes	0.003	0.997	0.000
I25.6 Silent myocardial ischaemia	0.003	0.997	0.000
Y46.4 Iminostilbenes	0.003	0.997	0.000
Y46.2 Hydantoin derivatives	0.003	0.997	0.000
Y42.7 Androgens and anabolic congeners	0.003	0.997	0.000
S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level	0.000	0.997	0.003
F60.0 Paranoid personality disorder	0.000	0.997	0.003
Y59.3 Immunoglobulin	0.003	0.997	0.000
Y42.5 Other oestrogens and progestogens	0.003	0.997	0.000
Y46.8 Antispasticity drugs	0.003	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.997	0.000
Y46.5 Valproic acid	0.003	0.997	0.000
Y46.3 Deoxybarbiturates	0.003	0.997	0.000
Y46.1 Oxazolidinediones	0.003	0.997	0.000
Y46.0 Succinimides	0.003	0.997	0.000
Y47.1 Benzodiazepines	0.003	0.997	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
S71 Open wound of hip and thigh	0.003	0.997	0.000
Y49.2 Other and unspecified antidepressants	0.003	0.997	0.000
F60.5 Anankastic personality disorder	0.000	0.997	0.003
Y40.6 Rifamycins	0.003	0.997	0.000
F60.4 Histrionic personality disorder	0.000	0.997	0.003
F60.2 Dissocial personality disorder	0.000	0.997	0.003
F60.1 Schizoid personality disorder	0.000	0.997	0.003
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Y55.4 Expectorants	0.003	0.997	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
G00.9 Bacterial meningitis, unspecified	0.000	0.997	0.003
Y59.9 Vaccine or biological substance, unspecified	0.003	0.997	0.000
Y59.8 Other specified vaccines and biological substances	0.003	0.997	0.000
Y59.2 Protozoal vaccines	0.003	0.997	0.000
Y59.1 Rickettsial vaccines	0.003	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
I27.2 Other secondary pulmonary hypertension	0.000	0.997	0.003
M79.62 Pain in limb (Upper arm)	0.003	0.997	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
S02.00 Fracture of vault of skull (closed)	0.000	0.997	0.003
K02.8 Other dental caries	0.000	0.997	0.003
Y41.5 Antiviral drugs	0.003	0.997	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.997	0.000
Y47.4 Bromine compounds	0.002	0.997	0.000
Y47.3 Paraldehyde	0.002	0.997	0.000
Y47.2 Chloral derivatives	0.002	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.997	0.000
S71.0 Open wound of hip	0.003	0.997	0.000
Y42.4 Oral contraceptives	0.003	0.997	0.000
I25.3 Aneurysm of heart	0.003	0.997	0.000
S71.7 Multiple open wounds of of hip and thigh	0.002	0.997	0.000
R09 Other symptoms and signs involving the circulatory and respiratory systems	0.003	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.997	0.000
Y57.4 Pharmaceutical excipients	0.002	0.997	0.000
Y57.3 Alcohol deterrents	0.002	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.997	0.000
Y57.1 Lipotropic drugs	0.002	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.997	0.000
Q38 Other congenital malformations of tongue, mouth and pharynx	0.003	0.997	0.000
Y42.9 Other and unspecified hormone antagonists	0.002	0.997	0.000
Y54.7 Agents affecting calcification	0.002	0.997	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.997	0.000
Y55.5 Anticommon cold drugs	0.002	0.997	0.000
Y55.3 Antitussives	0.002	0.997	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.997	0.000
Y55.0 Oxytocic drugs	0.002	0.997	0.000
Y48.5 Therapeutic gases	0.002	0.997	0.000
Y48.1 Parenteral anaesthetics	0.002	0.997	0.000
Y48.0 Inhaled anaesthetics	0.002	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.997	0.000
S66.6 Injury of multiple flexor muscles and tendons at wrist and hand level	0.000	0.997	0.003
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.997	0.000
Y41.4 Anthelminthics	0.002	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.997	0.000
Y58.0 BCG vaccine	0.002	0.997	0.000
S02.4 Fracture of malar and maxillary bones	0.000	0.997	0.002
Y58.9 Other and unspecified bacterial vaccines	0.002	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.997	0.000
Y58.5 Diphtheria vaccine	0.002	0.997	0.000
Y58.4 Tetanus vaccine	0.002	0.997	0.000
Y58.3 Plague vaccine	0.002	0.997	0.000
Y58.2 Cholera vaccine	0.002	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.997	0.000
S02.70 Multiple fractures involving skull and facial bones (closed)	0.000	0.997	0.002
O04.7 Complete or unspecified, complicated by embolism	0.000	0.997	0.002
O04.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.000	0.997	0.002
O04.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.000	0.997	0.002
O04.3 Incomplete, with other and unspecified complications	0.000	0.997	0.002
O04.2 Incomplete, complicated by embolism	0.000	0.997	0.002
O04.0 Incomplete, complicated by genital tract and pelvic infection	0.000	0.997	0.002
Y50.9 Central nervous system stimulant, unspecified	0.002	0.997	0.000
Y50.8 Other central nervous system stimulants	0.002	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.997	0.000
Y50.1 Opioid receptor antagonists	0.002	0.997	0.000
Y50.0 Analeptics	0.002	0.997	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
F60.6 Anxious [avoidant] personality disorder	0.000	0.998	0.002
M50.1 Cervical disk disorder with radiculopathy	0.002	0.998	0.000
Q38.1 Ankyloglossia	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
O04.8 Complete or unspecified, with other and unspecified complications	0.000	0.998	0.002
R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems	0.002	0.998	0.000
S02.0 Fracture of vault of skull	0.000	0.998	0.002
S30.0 Contusion of lower back and pelvis	0.000	0.998	0.002
Y42.2 Antithyroid drugs	0.002	0.998	0.000
Y43.1 Antineoplastic antimetabolites	0.002	0.998	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.998	0.002
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
O04.4 Incomplete, without complication	0.000	0.998	0.002
Q87.4 Marfan's syndrome	0.000	0.998	0.002
S71.8 Open wound of other and unspecified parts of pelvic girdle	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.998	0.002
H21.8 Other specified disorders of iris and ciliary body	0.002	0.998	0.000
M79.66 Pain in limb (Lower leg)	0.002	0.998	0.000
K56.2 Volvulus	0.000	0.998	0.002
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
H21.5 Other adhesions and disruptions of iris and ciliary body	0.002	0.998	0.000
R09.1 Pleurisy	0.002	0.998	0.000
S02.7 Multiple fractures involving skull and facial bones	0.000	0.998	0.002
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
H21.0 Hyphaema	0.002	0.998	0.000
Q51.8 Other congenital malformations of uterus and cervix	0.002	0.998	0.000
S66.8 Injury of other muscles and tendons at wrist and hand level	0.000	0.998	0.002
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
H20.0 Acute and subacute iridocyclitis	0.002	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.000	0.998	0.002
Y53.4 Other laxatives	0.002	0.998	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
O73.1 Retained portions of placenta and membranes, without haemorrhage	0.000	0.998	0.002
Z73.3 Stress, not elsewhere classified	0.000	0.998	0.002
H15.1 Episcleritis	0.002	0.998	0.000
Y40.0 Penicillins	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
O73 Retained placenta and membranes, without haemorrhage	0.000	0.998	0.002
Q51 Congenital malformations of uterus and cervix	0.002	0.998	0.000
O24.0 Pre-existing diabetes mellitus, insulin-dependent	0.002	0.998	0.000
Q38.5 Congenital malformations of palate, not elsewhere classified	0.002	0.998	0.000
R09.2 Respiratory arrest	0.002	0.998	0.000
R09.0 Asphyxia	0.002	0.998	0.000
H21 Other disorders of iris and ciliary body	0.002	0.998	0.000
C26.0 Intestinal tract, part unspecified	0.002	0.998	0.000
Q51.2 Other doubling of uterus	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
S02 Fracture of skull and facial bones	0.000	0.998	0.002
I25.0 Atherosclerotic cardiovascular disease, so described	0.002	0.998	0.000
Q38.8 Other congenital malformations of pharynx	0.002	0.998	0.000
Q38.4 Congenital malformations of salivary glands and ducts	0.002	0.998	0.000
Q38.3 Other congenital malformations of tongue	0.002	0.998	0.000
Q38.2 Macroglossia	0.002	0.998	0.000
Q38.0 Congenital malformations of lips, not elsewhere classified	0.002	0.998	0.000
S66.0 Injury of long flexor muscle and tendon of thumb at wrist and hand level	0.000	0.998	0.002
T18.1 Foreign body in oesophagus	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
H27.8 Other specified disorders of lens	0.002	0.998	0.000
I25.9 Chronic ischaemic heart disease, unspecified	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
C83.7 Burkitt's tumour	0.000	0.998	0.002
O24.4 Diabetes mellitus arising in pregnancy	0.002	0.998	0.000
Y43.3 Other antineoplastic drugs	0.002	0.998	0.000
S66 Injury of muscle and tendon at wrist and hand level	0.000	0.998	0.002
Q38.6 Other congenital malformations of mouth	0.002	0.998	0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.002	0.998	0.000
Q51.1 Doubling of uterus with doubling of cervix and vagina	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
S02.8 Fractures of other skull and facial bones	0.000	0.998	0.002
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
S02.01 Fracture of vault of skull (open)	0.000	0.998	0.002
S02.41 Fracture of malar and maxillary bones (open)	0.000	0.998	0.002
C83.6 Undifferentiated (diffuse)	0.000	0.998	0.002
C83.4 Immunoblastic (diffuse)	0.000	0.998	0.002
C83.2 Mixed small and large cell (diffuse)	0.000	0.998	0.002
C83.1 Small cleaved cell (diffuse)	0.000	0.998	0.002
O24.9 Diabetes mellitus in pregnancy, unspecified	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
H26.1 Traumatic cataract	0.000	0.998	0.002
Z90.0 Acquired absence of part of head and neck	0.000	0.998	0.002
S02.21 Fracture of nasal bones (open)	0.000	0.998	0.002
S76.4 Injury of other and unspecified muscles and tendons at thigh level	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
S02.71 Multiple fractures involving skull and facial bones (open)	0.000	0.998	0.002
N05.9 Unspecified	0.000	0.998	0.002
S02.2 Fracture of nasal bones	0.000	0.998	0.002
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
Z37.2 Twins, both liveborn	0.000	0.998	0.002
S02.80 Fractures of other skull and facial bones (closed)	0.000	0.998	0.002
C83.5 Lymphoblastic (diffuse)	0.000	0.998	0.002
H20.9 Iridocyclitis, unspecified	0.002	0.998	0.000
Q51.4 Unicornate uterus	0.002	0.998	0.000
S02.9 Fracture of skull and facial bones, part unspecified	0.000	0.998	0.002
O24 Diabetes mellitus in pregnancy	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
H21.3 Cyst of iris, ciliary body and anterior chamber	0.002	0.998	0.000
K09.8 Other cysts of oral region, not elsewhere classified	0.002	0.998	0.000
Q51.9 Congenital malformation of uterus and cervix, unspecified	0.002	0.998	0.000
Q51.7 Congenital fistulae between uterus and digestive and urinary tracts	0.002	0.998	0.000
Q51.6 Embryonic cyst of cervix	0.002	0.998	0.000
Q51.5 Agenesis and aplasia of cervix	0.002	0.998	0.000
Q51.0 Agenesis and aplasia of uterus	0.002	0.998	0.000
H21.4 Pupillary membranes	0.002	0.998	0.000
Q51.3 Bicornate uterus	0.002	0.998	0.000
R68.8 Other specified general symptoms and signs	0.002	0.998	0.000
H21.9 Disorder of iris and ciliary body, unspecified	0.002	0.998	0.000
Q38-Q45 Other congenital malformations of the digestive system	0.002	0.998	0.000
I25.2 Old myocardial infarction	0.002	0.998	0.000
S02.6 Fracture of mandible	0.000	0.998	0.002
H20 Iridocyclitis	0.002	0.998	0.000
S66.5 Injury of intrinsic muscle and tendon of other finger at wrist and hand level	0.000	0.998	0.002
S66.4 Injury of intrinsic muscle and tendon of thumb at wrist and hand level	0.000	0.998	0.002
Q44 Congenital malformations of gallbladder, bile ducts and liver	0.002	0.998	0.000
S76 Injury of muscle and tendon at hip and thigh level	0.002	0.998	0.000
M40.24 Other and unspecified kyphosis (Thoracic region)	0.000	0.998	0.002
M79.10 Myalgia (Multiple sites)	0.002	0.998	0.000
H21.1 Other vascular disorders of iris and ciliary body	0.002	0.998	0.000
Q44.4 Choledochal cyst	0.002	0.998	0.000
S66.7 Injury of multiple extensor muscles and tendons at wrist and hand level	0.000	0.998	0.002
Q39 Congenital malformations of oesophagus	0.002	0.998	0.000
M77.02 Medial epicondylitis (Upper arm)	0.000	0.998	0.002
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.001	0.998	0.000
G00 Bacterial meningitis, not elsewhere classified	0.000	0.998	0.002
S02.81 Fractures of other skull and facial bones (open)	0.000	0.998	0.002
D37.5 Rectum	0.000	0.998	0.002
Q39.4 Oesophageal web	0.002	0.998	0.000
Q50.5 Embryonic cyst of broad ligament	0.002	0.998	0.000
S79.8 Other specified injuries of hip and thigh	0.002	0.998	0.000
S79 Other and unspecified injuries of hip and thigh	0.002	0.998	0.000
D40.1 Testis	0.002	0.998	0.000
G00.1 Pneumococcal meningitis	0.000	0.998	0.002
J30.1 Allergic rhinitis due to pollen	0.000	0.998	0.002
S27.0 Traumatic pneumothorax	0.000	0.998	0.002
Q74.2 Other congenital malformations of lower limb(s), including pelvic girdle	0.002	0.998	0.000
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.000	0.998	0.002
H21.2 Degeneration of iris and ciliary body	0.002	0.998	0.000
V48.4 Person injured while boarding or alighting	0.002	0.998	0.000
Q50.0 Congenital absence of ovary	0.002	0.998	0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.002	0.998	0.000
O24.3 Pre-existing diabetes mellitus, unspecified	0.001	0.998	0.000
O24.2 Pre-existing malnutrition-related diabetes mellitus	0.001	0.998	0.000
O24.1 Pre-existing diabetes mellitus, noninsulin-dependent	0.001	0.998	0.000
Y57.5 X-ray contrast media	0.001	0.998	0.000
M79.60 Pain in limb (Multiple sites)	0.002	0.998	0.000
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.000	0.998	0.001
H31.0 Chorioretinal scars	0.002	0.998	0.000
Q40.1 Congenital hiatus hernia	0.001	0.998	0.000
Q44.7 Other congenital malformations of liver	0.001	0.998	0.000
Q74.1 Congenital malformation of knee	0.002	0.998	0.000
R45.1 Restlessness and agitation	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.001	0.998	0.000
R68.3 Clubbing of fingers	0.002	0.998	0.000
Q74 Other congenital malformations of limb(s)	0.002	0.998	0.000
F60-F69 Disorders of adult personality and behaviour	0.000	0.998	0.002
S70-S79 Injuries to the hip and thigh	0.002	0.998	0.000
M25.66 Stiffness of joint, not elsewhere classified (Lower leg)	0.000	0.998	0.002
H20.8 Other iridocyclitis	0.002	0.998	0.000
O02.0 Blighted ovum and nonhydatidiform mole	0.000	0.998	0.002
Y54.8 Agents affecting uric acid metabolism	0.001	0.998	0.000
S92.70 Multiple fractures of foot (closed)	0.002	0.998	0.000
S02.1 Fracture of base of skull	0.000	0.998	0.002
S79.9 Unspecified injury of hip and thigh	0.002	0.998	0.000
Z52.4 Kidney donor	0.000	0.998	0.002
Q15.0 Congenital glaucoma	0.001	0.998	0.000
H15 Disorders of sclera	0.002	0.998	0.000
Q42 Congenital absence, atresia and stenosis of large intestine	0.001	0.998	0.000
Q41 Congenital absence, atresia and stenosis of small intestine	0.001	0.998	0.000
Q40 Other congenital malformations of upper alimentary tract	0.001	0.998	0.000
S02.61 Fracture of mandible (open)	0.000	0.998	0.001
H20.2 Lens-induced iridocyclitis	0.001	0.998	0.000
J39.8 Other specified diseases of upper respiratory tract	0.002	0.998	0.000
Q44.3 Congenital stenosis and stricture of bile ducts	0.001	0.998	0.000
Q44.2 Atresia of bile ducts	0.001	0.998	0.000
Q44.1 Other congenital malformations of gallbladder	0.001	0.998	0.000
Q44.0 Agenesis, aplasia and hypoplasia of gallbladder	0.001	0.998	0.000
G00.2 Streptococcal meningitis	0.000	0.998	0.001
Q39.9 Congenital malformation of oesophagus, unspecified	0.001	0.998	0.000
Q39.8 Other congenital malformations of oesophagus	0.001	0.998	0.000
Q39.5 Congenital dilatation of oesophagus	0.001	0.998	0.000
Q39.3 Congenital stenosis and stricture of oesophagus	0.001	0.998	0.000
Q39.2 Congenital tracheooesophageal fistula without atresia	0.001	0.998	0.000
Q39.1 Atresia of oesophagus with tracheooesophageal fistula	0.001	0.998	0.000
Q39.0 Atresia of oesophagus without fistula	0.001	0.998	0.000
S76.1 Injury of quadriceps muscle and tendon	0.001	0.998	0.000
S76.7 Injury of multiple muscles and tendons at hip and thigh level	0.001	0.998	0.000
S76.2 Injury of adductor muscle and tendon of thigh	0.001	0.998	0.000
S76.0 Injury of muscle and tendon of hip	0.001	0.998	0.000
Z56.6 Other physical and mental strain related to work	0.001	0.998	0.000
F61 Mixed and other personality disorders	0.000	0.998	0.001
M70.22 Olecranon bursitis-Upper arm	0.001	0.998	0.000
M70.46 Prepatellar bursitis-Lower Leg	0.001	0.998	0.000
G00.8 Other bacterial meningitis	0.000	0.998	0.001
G00.3 Staphylococcal meningitis	0.000	0.998	0.001
G00.0 Haemophilus meningitis	0.000	0.998	0.001
O30.0 Twin pregnancy	0.000	0.998	0.002
Q10.0 Congenital ptosis	0.001	0.998	0.000
Q39.6 Diverticulum of oesophagus	0.001	0.998	0.000
S02.5 Fracture of tooth	0.000	0.998	0.001
S76.3 Injury of muscle and tendon of the posterior muscle group at thigh level	0.001	0.998	0.000
Y54.5 Other diuretics	0.001	0.998	0.000
Q15 Other congenital malformations of eye	0.001	0.998	0.000
K57.1 Diverticular disease of small intestine without perforation or abscess	0.002	0.998	0.000
S79.7 Multiple injuries of hip and thigh	0.001	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.001	0.998	0.000
F62 Enduring personality changes, not attributable to brain damage and disease	0.000	0.998	0.001
Q10 Congenital malformations of eyelid, lachrymal apparatus and orbit	0.001	0.998	0.000
M79.64 Pain in limb (Hand)	0.001	0.999	0.000
A69.2 Lyme disease	0.000	0.999	0.001
D40.0 Prostate	0.001	0.999	0.000
I45.2 Bifascicular block	0.001	0.999	0.000
M30.1 Polyarteritis with lung involvement [Churg-Strauss]	0.000	0.999	0.001
M79.6 Pain in limb	0.001	0.999	0.000
Q44.6 Cystic disease of liver	0.001	0.999	0.000
Q44.5 Other congenital malformations of bile ducts	0.001	0.999	0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.001	0.999	0.000
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament	0.001	0.999	0.000
Q50.3 Other congenital malformations of ovary	0.001	0.999	0.000
Q50.2 Congenital torsion of ovary	0.001	0.999	0.000
Q50.1 Developmental ovarian cyst	0.001	0.999	0.000
S02.3 Fracture of orbital floor	0.000	0.999	0.001
Q45 Other congenital malformations of digestive system	0.001	0.999	0.000
Q50-Q56 Congenital malformations of genital organs	0.001	0.999	0.000
S02.60 Fracture of mandible (closed)	0.000	0.999	0.001
S27.01 Traumatic pneumothorax (with open wound into thoracic cavity)	0.000	0.999	0.001
J01.9 Acute sinusitis, unspecified	0.000	0.999	0.001
Y54.3 Benzothiadiazine derivatives	0.001	0.999	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.000	0.999	0.001
H15.8 Other disorders of sclera	0.001	0.999	0.000
O32.1 Maternal care for breech presentation	0.000	0.999	0.001
Q74.0 Other congenital malformations of upper limb(s), including shoulder girdle	0.001	0.999	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.000	0.999	0.001
F65 Disorders of sexual preference	0.000	0.999	0.001
F63 Habit and impulse disorders	0.000	0.999	0.001
Q18 Other congenital malformations of face and neck	0.001	0.999	0.000
Q16 Congenital malformations of ear causing impairment of hearing	0.001	0.999	0.000
I85.9 Oesophageal varices without bleeding	0.001	0.999	0.000
Q18.1 Preauricular sinus and cyst	0.001	0.999	0.000
Q40.8 Other specified congenital malformations of upper alimentary tract	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations